DH vs. TUYA, EXFY, LPSN, CXM, LSPD, MGNI, SEMR, EVCM, CERT, and IAS
Should you be buying Definitive Healthcare stock or one of its competitors? The main competitors of Definitive Healthcare include Tuya (TUYA), Expensify (EXFY), LivePerson (LPSN), Sprinklr (CXM), Lightspeed Commerce (LSPD), Magnite (MGNI), Semrush (SEMR), EverCommerce (EVCM), Certara (CERT), and Integral Ad Science (IAS).
Definitive Healthcare (NASDAQ:DH) and Tuya (NYSE:TUYA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking and valuation.
Tuya has a net margin of -6.20% compared to Definitive Healthcare's net margin of -156.65%. Definitive Healthcare's return on equity of 0.98% beat Tuya's return on equity.
Tuya has higher revenue and earnings than Definitive Healthcare. Tuya is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.
Definitive Healthcare received 16 more outperform votes than Tuya when rated by MarketBeat users. However, 38.89% of users gave Tuya an outperform vote while only 28.40% of users gave Definitive Healthcare an outperform vote.
In the previous week, Definitive Healthcare had 1 more articles in the media than Tuya. MarketBeat recorded 2 mentions for Definitive Healthcare and 1 mentions for Tuya. Definitive Healthcare's average media sentiment score of 0.81 beat Tuya's score of 0.01 indicating that Definitive Healthcare is being referred to more favorably in the media.
Definitive Healthcare has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Tuya has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500.
98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 11.5% of Tuya shares are held by institutional investors. 14.8% of Definitive Healthcare shares are held by insiders. Comparatively, 2.1% of Tuya shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Definitive Healthcare presently has a consensus price target of $5.64, suggesting a potential upside of 33.09%. Tuya has a consensus price target of $2.70, suggesting a potential upside of 90.14%. Given Tuya's stronger consensus rating and higher possible upside, analysts clearly believe Tuya is more favorable than Definitive Healthcare.
Summary
Definitive Healthcare beats Tuya on 9 of the 17 factors compared between the two stocks.
Get Definitive Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for DH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Definitive Healthcare Competitors List
Related Companies and Tools
Free DH Stock Alerts